1. Home
  2. SVC vs CLLS Comparison

SVC vs CLLS Comparison

Compare SVC & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SVC

Service Properties Trust

HOLD

Current Price

$1.51

Market Cap

349.6M

Sector

Real Estate

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$3.91

Market Cap

384.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVC
CLLS
Founded
1995
1999
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.6M
384.3M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
SVC
CLLS
Price
$1.51
$3.91
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$2.50
$8.33
AVG Volume (30 Days)
13.6M
26.7K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
2.67%
N/A
EPS Growth
26.95
N/A
EPS
N/A
N/A
Revenue
$1,814,838,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.39
$0.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$1.33
52 Week High
$3.08
$5.48

Technical Indicators

Market Signals
Indicator
SVC
CLLS
Relative Strength Index (RSI) 46.01 47.05
Support Level $1.13 $3.39
Resistance Level $1.62 $3.83
Average True Range (ATR) 0.09 0.17
MACD 0.03 -0.03
Stochastic Oscillator 59.68 7.38

Price Performance

Historical Comparison
SVC
CLLS

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: